M&A Deal Summary

Breckenridge Pharmaceutical Acquires Cypress Pharmaceutical

On September 11, 2013, Breckenridge Pharmaceutical acquired life science company Cypress Pharmaceutical from TA Associates

Acquisition Highlights
  • This is Breckenridge Pharmaceutical’s 1st transaction in the Life Science sector.
  • This is Breckenridge Pharmaceutical’s 1st transaction in the United States.
  • This is Breckenridge Pharmaceutical’s 1st transaction in Mississippi.

M&A Deal Summary
Date 2013-09-11
Target Cypress Pharmaceutical
Sector Life Science
Buyer(s) Breckenridge Pharmaceutical
Sellers(s) TA Associates
Deal Type Add-on Acquisition

Target

Cypress Pharmaceutical

Madison, Mississippi, United States
website
Cypress Pharmaceutical is a rapidly growing specialty pharmaceutical company that develops, markets and distributes generic prescription, over-the-counter and specialty branded pharmaceutical products. Cypress provides generic and branded products to the leading national pharmaceutical wholesalers, chain drug stores, distributors and other retail merchandisers. Through its specialty branded business, Hawthorn Pharmaceuticals, the company also provides internally developed pharmaceutical products marketed directly to physician specialists.

Search 192,510 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Breckenridge Pharmaceutical

Boca Raton, Florida, United States

website

Category Company
Sector Healthcare Services
DESCRIPTION

Breckenridge Pharmaceutical, Inc. engages in the research, development, and marketing of generic pharmaceuticals in various therapeutic categories.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Mississippi) 1 of 1
Country (United States) 1 of 1
Year (2013) 1 of 1

Seller(S) 1

SELLER

TA Associates

Boston, Massachusetts, United States

Investor Investor Investor Investor Investor

website

Category Private Equity Firm
Founded 1968
PE ASSETS 65.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

TA Associates is a private equity firm that targets investments in middle-market and large companies around the world. TA will consider control or minority investments in profitable companies and looks to commit between $70 and $500 million per transaction. TA proactively reaches out to companies directly in sourcing potential investment opportunities. Prospective businesses are generally valued between $100 million and $3 billion. Areas of interest include technology, software, communications, financial services, healthcare, business services, semiconductors/electronics, and consumer products/services. In addition to investing equity capital, TA also makes subordinated debt investments. TA's geographic preference is North America, Asia/Pacific, and Europe. TA Associates was formed in 1968 and is based in Boston, Massachusetts.

DEAL STATS #
Overall 167 of 252
Sector (Life Science) 5 of 7
Type (Add-on Acquisition) 96 of 129
State (Mississippi) 2 of 3
Country (United States) 153 of 206
Year (2013) 5 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-09-11 BluePay

Naperville, Illinois, United States

BluePay is a provider of technology-enabled credit card payment processing services for enterprise, small and medium-sized businesses in the United States and Canada. BluePay Processing is based in Naperville, Illinois.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-09-17 SoftWriters

Allison Park, Pennsylvania, United States

SoftWriters, Inc. is a software solution provider servicing pharmacies that provide care to long term post-acute care patients, assisted living residents, independent living residents, pharmacies servicing group homes, correctional facilities, specialty pharmacies, and pharmacies servicing 340B contracts.

Buy -
Mergr

Product

Company

Legal